Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) is a combination antimalarial used for treating and preventing malaria caused by Plasmodium species. Malaria is a life-threatening disease transmitted through the bite of infected mosquitoes. Prompt treatment is essential to prevent severe complications. Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) offers fast, effective, and reliable treatment through a combination of artemisinin and piperaquine, which work together to eliminate malaria parasites from the bloodstream.

What Is Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)?

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) contains a fixed-dose combination of two antimalarial agents:

• Artemisinin 62.50mg – a fast-acting component that rapidly kills malaria parasites.

• Piperaquine 375mg – a long-acting antimalarial that prevents parasite regrowth and maintains therapeutic levels.

This combination ensures rapid clearance of parasites and reduces the risk of recurrence or resistance.

How Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) Works

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) works in two stages:

1. Artemisinin quickly attacks the parasite, reducing the parasite load in the bloodstream within hours.

2. Piperaquine has a longer half-life, maintaining antimalarial activity to prevent regrowth of parasites and providing sustained protection.

The dual-action mechanism makes Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) highly effective against both acute and recurring malaria infections.

Uses of Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) is primarily used for:

• Treatment of uncomplicated malaria caused by Plasmodium falciparum and Plasmodium vivax

• Prevention of malaria in high-risk regions

• Reducing parasite load during malaria infection

• Supporting recovery and symptom relief from fever, chills, and body aches

Healthcare professionals determine the appropriate regimen based on patient condition, age, and local malaria resistance patterns.

Benefits of Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)

• Rapid relief from malaria symptoms such as fever and fatigue

• Dual-action therapy reduces recurrence and resistance risk

• Safe and effective when used as prescribed

• Convenient oral dosing for home or hospital use

• Clinically tested for malaria prevention and treatment

These benefits make Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) a preferred antimalarial in endemic areas.

Dosage and Administration

• Dosage is determined by the patient’s weight, age, and severity of infection

• Tablets should be swallowed with water, preferably with food to reduce stomach discomfort

• Complete the full course even if symptoms improve to prevent recurrence

• Follow the healthcare provider’s instructions carefully for maximum effectiveness

Proper administration ensures complete parasite clearance and reduces the risk of treatment failure.

Who Can Use Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) may be suitable for:

• Adults and children above the recommended age and weight

• Individuals diagnosed with uncomplicated malaria

• Travelers to malaria-endemic regions under preventive guidance

Medical supervision is required to ensure correct dosing and safe use.

Who Should Avoid Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) should be avoided by individuals who:

• Are allergic to artemisinin, piperaquine, or related compounds

• Have a history of heart rhythm disorders

• Are pregnant or breastfeeding without medical advice

• Suffer from severe liver or kidney disorders

A healthcare professional should assess suitability before starting treatment.

Possible Side Effects

Most patients tolerate Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) well. Mild side effects may include:

• Nausea or vomiting

• Dizziness or headache

• Stomach discomfort or diarrhea

• Mild fatigue

Serious side effects, such as heart rhythm disturbances, severe allergic reactions, or persistent vomiting, require immediate medical attention.

Precautions and Safety Information

• Take the full course of Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) even if symptoms improve

• Avoid alcohol and other medications that may affect heart rhythm

• Inform your doctor about all medications, allergies, and existing medical conditions

• Monitor for unusual symptoms such as palpitations, severe dizziness, or rash

Adhering to these precautions ensures effective and safe malaria management.

Drug Interactions

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) may interact with:

• Medications that prolong the QT interval

• Certain antibiotics and antifungal drugs

• Anticonvulsants or other malaria treatments

Disclose all medications to your healthcare provider to avoid harmful interactions.

Storage Instructions

Store Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) at room temperature (15–30°C), away from heat, moisture, and direct sunlight. Keep out of reach of children. Proper storage preserves potency and ensures safety.

Why Choose Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)

Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) provides fast and reliable relief from malaria with dual-action therapy. Clinically proven, safe, and effective under medical supervision, it reduces parasite load, prevents recurrence, and improves recovery from malaria symptoms. This makes it a preferred choice for both treatment and prophylaxis in malaria-endemic regions.

FAQs – Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)

Q1. What is Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) used for?
It is used for the treatment and prevention of malaria caused by Plasmodium species.

Q2. How should Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) be taken?
Swallow the tablet with water as prescribed by a healthcare professional, and complete the full course.

Q3. Can Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg) be used for prevention?
Yes, it can be used as malaria prophylaxis under medical supervision.

Q4. Are there side effects of Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)?
Mild nausea, dizziness, headache, or stomach discomfort may occur; serious side effects are rare.

Q5. Who should avoid Relinquish-M Tablet (Artemisinin 62.50mg + Piperaquine 375mg)?
Individuals allergic to its components, with heart disorders, severe liver/kidney issues, or pregnant women should avoid it unless prescribed.